Ablynx CEO Dr Edwin Moses prefers alliance with companies then to buy them
Belgian bio-pharmaceutical company Ablynx (ABLX) is seeking partners to help it deliver its ultra-small antibody fragments to patients and does not rule out itself being snapped up by a larger company.
Dr Edwin Moses, CEO and Chairman of Ablynx [...]
Top 10 Stock Picks For Long-Term Investors
Amazon (AMZN)- Amazon.com, Inc. operates as an online retailer in North America and internationally. The company operates various retail Web sites, including amazon.com, amazon.co.uk, amazon.de, amazon.fr, amazon.co.jp, amazon.ca, and amazon.cn. [...]
German drug and chemical maker Merck KGaA net income falls
German pharmaceutical and chemical company Merck KGaA (MRCG.DE) said Monday its third-quarter net profit fell 27.8% to 144.4 million euros ($217 million) from the same period a year ago.
Its third-quarter revenue rose 2.7% to 1.94 billion euros [...]
Merck Profit Falls 57%, Misses Analysts Estimates, Amid Yr-Ago Gain, Sales Drop
Merck & Co., Inc. today announced financial results for the first quarter of 2009. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the quarter of $0.74, which excludes $0.07 of restructuring [...]
Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
Merck & Co., Inc., (through an affiliate), Medarex, Inc. (NASDAQ: MEDX) and Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) today announced that they have signed an exclusive worldwide license [...]
A review on Merck and Schering-Plough $41.1B deal!
The Merck/Schering-Plough deal follows on the heels of New Jersey-based pharmaceutical company, Pfizer’s $68 billion purchase of Wyeth. Merck & Co Inc, a global research-driven pharmaceutical company said, that it would acquire Schering-Plough [...]
